- Accession Number
Organic compounds that contain 1,2-diphenylethylene as a functional group.
Drug Drug Description Diethylstilbestrol Used in the treatment of prostate cancer. Previously used in the prevention of miscarriage or premature delivery in pregnant women prone to miscarriage or premature delivery. Chlorotrianisene Used to treat symptoms of menopause, deficiencies in ovary function (including underdevelopment of female sexual characteristics and some types of infertility), and in rare cases, prostate cancer. Chlorotrianisene may also... Raloxifene A selective estrogen receptor modulator that is used to prevent and treat osteoporosis and reduce the risk of invasive breast cancer in high-risk postmenopausal women. Toremifene A first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers. Tamoxifen A selective estrogen receptor modulator used to treat estrogen receptor positive breast cancer, reduce the risk of invasive breast cancer following surgery, or reduce the risk of breast cancer in high risk women. Clomifene A medication used to induce ovulation. Afimoxifene For the potential treatment of menstrual-cycle related mastalgia, fibrocystic breast disease, breast disease, gynecomastia and Keloid scarring. Ospemifene A non-hormonal estrogen receptor modulator (SERM) used to treat moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. Fispemifene Investigated for use/treatment in male hormonal deficiencies/abnormalities. Enclomiphene Not Annotated Hexestrol A synthetic estrogen that has been used as a hormonal antineoplastic agent. Combretastatin Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer. Hydroxystilbamidine Used in the treatment of nonprogressive blastomycosis of the skin and other mycoses. Resveratrol Being investigated for the treatment of Herpes labialis infections (cold sores). Droloxifene Droloxifene, a derivative of the triphenylethylene drug tamoxifen, is a novel selective estrogen receptor modulator (SERM). Droloxifene also exhibits more rapid pharmacokinetics, reaching peak concentrations and being eliminated much more...
- Drugs & Drug Targets